The use of two plasma derived factor VIII concentrates in type 2 a von Willebrand's disease (VWD).

被引：0
作者：
Hampton, KK [1 ]
Makris, M [1 ]
机构：
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4103
引用
收藏
页码：99B / 99B
页数：1
相关论文
共 50 条
  • [31] Use of objective efficacy criteria for evaluation of von willebrand factor/factor VIII concentrates
    Kessler, Craig M.
    Windyga, Jerzy
    Schwartz, Bruce A.
    Knaub, Sigurd
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (04) : 262 - 267
  • [32] Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gatrointestinal bleeding in patients with von Willebrand type III disease
    Zanon, E
    Vianello, F
    Casonato, A
    Girolami, A
    HAEMOPHILIA, 2001, 7 (05) : 500 - 503
  • [33] A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease
    Rugeri, Lucia
    Thomas, Will
    Schirner, Kathrin
    Heyder, Lisa
    Auerswald, Guenter
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (09) : 828 - 841
  • [34] Severe Traumatic Brain Injury in a Patient with von Willebrand Disease Type 2A Successfully Treated with Factor VIII/von Willebrand Factor Concentrates: A Case Report
    Koroki, Takatoshi
    Abe, Tomohiro
    Kamimura, Sachiyo
    Ochiai, Hidenobu
    AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
  • [35] Pharmacokinetics of von Willebrand factor (human) in patients with von Willebrand disease (vWD)
    Menache, D
    Aronson, DL
    Kennedy, D
    Montgomery, RR
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2097 - P2097
  • [36] Combined hemophilia A and type 2N von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor
    Casonato, A
    Pontara, E
    Sartorello, F
    Gemmati, D
    Cattini, MG
    Girolami, A
    HAEMATOLOGICA, 2001, 86 (10) : 1110 - 1111
  • [37] Von Willebrand factor/factor VIII concentrate (Humate-P®) for surgical prophylaxis of excessive bleeding in patients with von Willebrand disease (VWD).
    Gill, JC
    DiPaola, J
    Bernstein, J
    Leissinger, CA
    Valentino, L
    Friedman, C
    Knaub, S
    BLOOD, 2005, 106 (11) : 509A - 509A
  • [38] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 46 - 47
  • [39] Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models
    Denis, CV
    Kwack, K
    Saffaripour, S
    Maganti, S
    André, P
    Schaub, RG
    Wagner, DD
    BLOOD, 2001, 97 (02) : 465 - 472
  • [40] Effect of Factor VIII and Von Willebrand Factor Activities on Number of Bleeding Events in Previously Treated Patients with Von Willebrand Disease on Regular Prophylaxis with a Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate
    Vilchevska, Kateryna V.
    Vdovin, Vladimir
    Timofeeva, Margarita
    Khayat, Claudia Djambas
    Inati, Adlette
    Robert, Sidonio F., Jr.
    BLOOD, 2023, 142
12345